25 Best & 10 Cheapest Dividend Aristocrats

2021-09-15

Dividend Aristocrats

Dividend Aristocrats that look very attractively valued today. I often get asked if I could give a list of my best stocks to invest in.  Unfortunately, that is a very loaded question simply because the best stocks (businesses) are not always the best investments.  That pesky valuation often gets in the way.  This is especially true in today’s very expensive stock market.  The best stocks on the planet are not a secret, and as a result, investors tend to bid them up to unrealistic valuation levels.  On the other hand, it is also possible that the cheapest stocks may not be the absolute best businesses, but because they are undervalued, they can be the best investments – at least over the near to intermediate term.

With this video I am going to cover the vaulted Standard & Poor’s Dividend Aristocrats list of companies.  These are blue-chip dividend paying stocks that have increased their dividend for at least 25 consecutive years or longer.  In short, they are among the crème de la crème of all dividend paying stocks based on the longevity of their dividend increase streaks.  Unfortunately, in today’s overheated stock market, most of the Dividend Aristocrats are overvalued and therefore not necessarily attractive investments at least over the near to intermediate term. 

Once again, this is especially true of the best of breed Dividend Aristocrats.  In contrast, there are Dividend Aristocrats that look very attractively valued today.  But unfortunately, they are not necessarily the best Dividend Aristocrats on the list.  Nevertheless, by virtue of the fact that they are Dividend Aristocrats implies that they are quality companies.  Therefore, I will attempt to convey the difference between the best versus the cheapest.  I will leave it up to the individual to decide what is suitable for themselves.

25 Best & 10 Cheapest

In this FAST Graphs Analyze Out Loud Video I will review:  S&P Global (SPGI), Atmos Energy (ATO), McCormick & Co (MKC), Sherwin Williams (SHW), Air Products & Chemicals (APD), Stanley Black & Decker (SWK), Automatic Data Processing (ADP), Becton Dickinson (BDX), General Dynamics (GD), Expeditors International of Washington (EXPD), Medtronic (MDT), Johnson & Johnson (JNJ), Linde (LIN), PepsiCo (PEP), Illinois Tool Works (ITW), 3M (MMM), Ecolab (ECL), Target (TGT), Lowes (LOW), McDonalds (MCD), WW Grainger (GWW), Hormel Foods (HRL), Roper Technologies (ROP), Nextera Energy (NEE), Realty Income Corp (O), Walgreens Boots Alliance (WBA), International Business Machines (IBM), AbbVie (ABBV), Peoples United Financial (PBCT), Franklin Resources (BEN), Nucor Corp (NUE), AT&T (T), Aflac (AFL), Cardinal Health (CAH), Archer Daniels Midland (ADM)

FAST Graphs Analyze Out Loud Video:

FAST Graphs Analyze Out Loud Video

Try FAST Graphs for FREE Today!

SUBSCRIBE to our YouTube Channel

Click here for our Research Articles

Disclosure: Long SWK, GD, MDT, JNJ, MMM, O, WBA, IBM, ABBV, T, AFL, CAH, ADM at the time of writing.

Disclaimer: The opinions in this document are for informational and educational purposes only and should not be construed as a recommendation to buy or sell the stocks mentioned or to solicit transactions or clients. Past performance of the companies discussed may not continue and the companies may not achieve the earnings growth as predicted. The information in this document is believed to be accurate, but under no circumstances should a person act upon the information contained within. We do not recommend that anyone act upon any investment information without first consulting an investment advisor as to the suitability of such investments for his specific situation.

Unlock data on thousands of companies

Disclaimers: F.A.S.T. Graphs, Inc. is not a broker-dealer or a registered investment adviser. Under no circumstances does any information on Fastgraphs.com constitute a recommendation to buy or sell a security, nor does it give investment advice. This is to include any publications or articles on Fastgraphs.com. Fastgraphs.com is a research tool to be used by its subscribers in conjunction with the subscribers’ additional research and due diligence. The information on this site is in no way guaranteed for completeness or accuracy.